文献速递免疫规划卫生政策与健康促进

欧洲50岁以上成人疫苗接种促进健康老龄化:前进之路

Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward.
PubMed 文献 · Vaccine · 2018-08-22

本文总结泛欧洲会议共识,指出从儿童期转向终身疫苗接种对预防老年人残疾、发病和死亡、促进健康老龄化至关重要。在资源减少的后真相媒体时代,需创新方法转变决策者思维,并建立多学科网络推动50岁以上成人疫苗接种。

要点

  • 从儿童期转向终身疫苗接种对预防老年人残疾、发病和死亡至关重要。
  • 转变决策者思维从治疗转向预防是应对挑战的创新方法。
  • 需建立包括卫生当局、多专科医生、社会学家、心理学家、制药公司和患者协会的欧洲多学科网络。

核心结论

  • 从儿童期转向终身疫苗接种对预防老年人残疾、发病和死亡、促进健康老龄化至关重要。
  • 应对疫苗接种转变的挑战需采用创新方法使决策者思维从治疗转向预防。
  • 需采取多项关键行动,并建立欧洲多学科网络。

研究设计与样本

  • 本文总结泛欧洲会议关于50岁以上成人疫苗接种缺口与障碍及欧洲进一步联合行动的共识要点。

主要发现

  • 全球≥65岁人口比例目前约17%,2050年将约27%。
  • 问题不在于老龄化本身,而在于与老龄化相关的个体残疾。
  • 疫苗接种转变在医疗资源减少的后真相媒体时代是重大挑战。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The proportion of the population ≥65 years old is about 17% today and will be about 27% in 2050 worldwide. The problem, however, is not ageing in itself, it is individual disabilities associated with ageing. This manuscript summarizes the consensus points reached during a pan-European meeting on gaps and barriers in making vaccination of adults aged 50+ a reality and on further joint actions in Europe. The shift from childhood to life-long vaccination is essential to prevent disability, morbidity and mortality in the elderly and promote healthy ageing. This vaccination shift is a major challenge in the post-truth, media-based era in countries with dwindling resources for the provision of healthcare. The challenge can be met only by adopting an innovative approach designed to shift the mindset of decision-makers from treatment to prevention. A number of key actions are required and for these actions a European multidisciplinary network including health authorities, medical doctors with different specialties, sociologists, psychologists, pharmaceutical companies and Associations of patients appears mandatory.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Esposito S, Principi N, Rezza G, et al. Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward. Vaccine. 2018. PMID: 30143273. doi:10.1016/j.vaccine.2018.08.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。